ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,729.76
      0.20%
      US Tech 100
      19,441.20
      0.62%
      Dow Jones
      42,165.16
      0.10%
      Brent Oil
      74.365
      0.85%
      Bitcoin
      63,154.75
      -0.27%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Evofem Biosciences Inc (EVFM) Quote

      Evofem Biosciences Inc

      Evofem Biosciences Inc (EVFM)

      Evofem Biosciences Inc (QB)
      0.4782
      0.00
      ( 0.00% )
      Updated: 20:00:00
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.4782
      Bid
      0.465
      Ask
      0.468
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      2.716M
      Previous Close
      0.4782
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      5,680,000
      Dividend Yield
      -
      PE Ratio
      0.11
      Earnings Per Share (EPS)
      8.8
      Revenue
      18.22M
      Net Profit
      50M

      About Evofem Biosciences Inc

      Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmi... Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.evofem.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -

      Ask ADVFN Intelligence (AI)

      EVFM Latest News

      More News

      FeaturedCannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference

      3 hours ago

      FeaturedIntegrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC.

      4 hours ago

      Biopharma Partners with Telemed Firm and Shares are Climbing

      This company is striving to change the narratives around women's healthcare and offering solutions that reinforce and improve them. And shares are responding positively to a recent partnership To...

      June 27 2024
      AllPennyStocks.com

      Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023

      Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023 PR Newswire SAN DIEGO, June 1, 2023 Increased net product revenue more than 35% in the first quarter of 2023...

      June 01 2023
      PR Newswire (US)

      Evofem Biosciences Announces 1-for-125 Reverse Stock Split

      Evofem Biosciences Announces 1-for-125 Reverse Stock Split PR Newswire SAN DIEGO, May 17, 2023 -- CUSIP number for Evofem will change to 30048L302 on May 18, 2023 -- -- Ticker symbol will change...

      May 17 2023
      PR Newswire (US)

      Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required

      Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required PR Newswire SAN DIEGO, April 12, 2023 — Improves Phexxi coverage for more than 5.8 million New York...

      April 12 2023
      PR Newswire (US)

      Evofem Biosciences Announces Cost Reduction Measures

      Evofem Biosciences Announces Cost Reduction Measures PR Newswire SAN DIEGO, March 21, 2023 – Company cuts management pay and lowers headcount to decrease operating costs – – Reductions align with...

      March 21 2023
      PR Newswire (US)

      Evofem Biosciences Appoints Interim Chief Financial Officer

      Evofem Biosciences Appoints Interim Chief Financial Officer PR Newswire SAN DIEGO, March 9, 2023 SAN DIEGO, March 9, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) is pleased to...

      March 09 2023
      PR Newswire (US)

      Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering

      Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering PR Newswire SAN DIEGO, Feb. 28, 2023 -- Phexxi is the first and only hormone-free contraceptive offered by reproductive...

      February 28 2023
      PR Newswire (US)

      Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi

      Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi PR Newswire SAN DIEGO, Feb. 27, 2023 -- Evofem now has four Orange Book listed patents covering...

      February 27 2023
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BNZIBanzai International Inc
      $ 8.801
      (109.55%)
      		44.73M
      SEELSeelos Therapeutics Inc
      $ 0.3811
      (100.58%)
      		281.79M
      MSSMaison Solutions Inc
      $ 1.41
      (97.20%)
      		76.53M
      XHGXChange TED Inc
      $ 1.04
      (67.88%)
      		19.71M
      WVEWave Life Sciences Ltd
      $ 7.9191
      (48.30%)
      		9.07M
      BIVIBioVie Inc
      $ 1.26
      (-55.00%)
      		1.62M
      GHSIGuardion Health Sciences Inc
      $ 6.4561
      (-38.63%)
      		278.2k
      XPONExpion360 Inc
      $ 0.0893
      (-23.68%)
      		30.76M
      FIACUFocus Impact Acquisition Corporation
      $ 9.10
      (-21.21%)
      		99
      OTRKOntrak Inc
      $ 2.70
      (-19.40%)
      		96.35k
      SEELSeelos Therapeutics Inc
      $ 0.3811
      (100.58%)
      		281.79M
      NVDANVIDIA Corporation
      $ 120.965
      (4.05%)
      		144.12M
      MLGOMicroAlgo Inc
      $ 0.2208
      (11.29%)
      		77.21M
      MSSMaison Solutions Inc
      $ 1.41
      (97.20%)
      		76.53M
      SQQQProShares UltraPro Short QQQ
      $ 7.6199
      (-1.93%)
      		75.43M

      Discussion

      View Full Feed
      MattyTrader MattyTrader 5 minutes ago
      Lol you don’t know that
      NWPN
      just Scottie just Scottie 5 minutes ago
      Company Biolase agreed to comply with certain process milestones which require, among other things, the entry into a purchase and sale agreement with a so-called "stalking horse bidder" SONX by September 30, 2024, filing a bankruptcy case by October 1, 2024, and closing the sale by November 15, 2024
      SONX
      Testpilot Testpilot 5 minutes ago
      The active anode material from the Endurion project will be superior in power density, cycle time, and recharge time. The nano particles are the difference maker in shorter recharge times and the artificial SEI is the game changer in cycle time.
      CRTG
      LutherTiggs LutherTiggs 6 minutes ago
      Bring on the frenzy!!! eom
      LWLG
      Drugdoctor Drugdoctor 6 minutes ago
      $MLGO .22 - NASDAQ - 79-million-VOLUME-Nice!
      MLGO
      Dubster watching Dubster watching 6 minutes ago
      Thank you sir. I appreciate your posts.
      I should be more careful with implied accusations but we are at war and I am doing my part against the principalities, and corruption all day.
      Most haven't realized the Lies from Liars are only the beginning of the great reveal.
      Blessings
      TSLA
      exwannabe exwannabe 6 minutes ago
      Thanks for posting, but you and Gro and others on your team have reposted that a hundred times.
      LOL. I am not aware of any "short" having reposted SOS's piece in full or part prior to me doings so. We generally consider it baseless pumping or else pre nonsense.

      But when first p
      NWBO
      robinandthe7hoods robinandthe7hoods 7 minutes ago
      They will be presenting at the Arcstone-Kingswood conference tomorrow.This PP will be oversubsrcibed,possibly up to $12 million.It should be announced in the next two weeks.
      They will be using the money for the execution of contracts,of which they have said will be a string of,and working
      VRSSF
      continuity continuity 7 minutes ago
      OK, i am in. how many 8s left?
      NBRI
      Dingbatt Dingbatt 7 minutes ago
      Contributing individuals to SEC rule changes
      https://www.sec.gov/rules-regulations/petitions-rulemaking-submitted-to-sec
      AEGY
      arizona1 arizona1 7 minutes ago
      I don't know if this is true but it makes sense.
      https://x.com/kemu808/status/1838596572080206003
      dstock07734 dstock07734 7 minutes ago
      Is it easy to detect all the mutated genes on cancer cells? Yes.
      But it is extremely challenging to find precision medicine the specific mutated genes highly overexpressed on cancer cells among tens of thousands ones. IMO, DCVax-L is going to make this job very easy. It is so easy that BPs do
      NWBO
      sloppyjones sloppyjones 7 minutes ago
      Lol. I wish I knew.

      They are definitely working behind the scenes.

      Still strange to see the progress while remaining in EM.

      Maybe it will be explained in time. Just glad to see progress and events back in action.
      TPTW
      learningcurve2020 learningcurve2020 8 minutes ago
      It's what they do best...Let enough time go by so green retail forget all the information comes from the disciples and not the company.
      NWBO
      exwannabe exwannabe 8 minutes ago
      Thanks for posting, but you and Gro and others on your team have reposted that a hundred times.
      LOL. I am not aware of any "short" having reposted SOS's piece in full or part prior to me doings so. We generally consider it baseless pumping or else pre nonsense.

      But when first p
      NWBO
      JJZander JJZander 8 minutes ago
      Nice slaps
      BNCM
      Money4Nothing-M4N Money4Nothing-M4N 9 minutes ago
      I believe the delisting process begins when they close below a dollar for 30 consecutive trading days.

      Can’t remember. Not sure
      KBLB
      Cashman17 Cashman17 9 minutes ago
      And who responded to your email Keith or MZ?
      EGYF
      double_m double_m 9 minutes ago
      "EV Manufacturer?" Mullen does NOT manufacture any EVs. Its business model is what's known as a Captive Imports arrangement. How can it become great when absolutely NO ONE is buying what its selling. How much confidence should anyone put in this new UAE venture they advertised? Track record says NON
      MULN
      double_m double_m 9 minutes ago
      "EV Manufacturer?" Mullen does NOT manufacture any EVs. Its business model is what's known as a Captive Imports arrangement. How can it become great when absolutely NO ONE is buying what its selling. How much confidence should anyone put in this new UAE venture they advertised? Track record says NON
      MULN
      bas2020 bas2020 9 minutes ago
      FOMO? Perhaps it's the reason the price is steadily rising.
      NWBO
      JusDePomme JusDePomme 9 minutes ago
      Not only here but all other penny stocks similar! Need something spark it
      AAPJ
      ksquared ksquared 9 minutes ago
      Ryan Routh’s confession letter shows how Democrats have stirred up violence against Trump
      By Daniel McCarthy Published Sep. 23, 2024, 7:38 p.m. ET

      The man who intended to murder Donald Trump on Sept. 18 has explained in his own words why he wanted to do it.

      The
      KngmAz KngmAz 9 minutes ago
      GOING - GOING - GONE!!
      MULN

      Your Recent History

      NASDAQ
      EVFM
      Evofem Biosciences
      Delayed Upgrade Clock